Patents by Inventor Sarah SEBASTIAN

Sarah SEBASTIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230310591
    Abstract: The invention relates to combinations, compositions, methods and dosage regimes for use in medicine, optionally wherein the use may be the treatment of chronic hepatitis B virus (HBV) infection or cancer, including inducing an improved immune response and improvement in the performance of therapeutic vaccines.
    Type: Application
    Filed: December 7, 2022
    Publication date: October 5, 2023
    Applicant: Vaccitech (UK) Limited
    Inventors: Thomas Evans, Sarah Sebastian
  • Publication number: 20230285532
    Abstract: The invention relates to a composition comprising a viral vector, the viral vector comprising nucleic acid having a polynucleotide sequence encoding the spike protein from the coronavirus SARS-CoV2, characterised in that said viral vector is an adenovirus based vector. The invention also relates to uses of such a composition and methods of treatment.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 14, 2023
    Inventors: Sarah C. GILBERT, Teresa LAMBE, Sarah SEBASTIAN
  • Publication number: 20220001007
    Abstract: The invention relates to a viral vector comprising nucleic acid having a polynucleotide sequence encoding at least one epitope of the varicella-zoster virus (VZV) Gly E antigen, wherein said viral vector is an adenoviral vector. The invention also relates to uses, compositions for use in medical treatments, and methods of medical treatment.
    Type: Application
    Filed: November 5, 2019
    Publication date: January 6, 2022
    Inventors: Sarah C. GILBERT, Sarah SEBASTIAN, Marta ULASZEWSKA, Adrian V.S. HILL, Teresa LAMBE